Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours

High-dose regimes containing etoposide, carboplatin and an oxazaphospharine can salvage 30–40% of patients with relapsed or refractory male germ cell tumours (GCTs). The additional benefit of paclitaxel in such high-dose therapy has not been tested. Between March 1995 and November 2002, 36 male GCT...

Descripción completa

Detalles Bibliográficos
Autores principales: McNeish, I A, Kanfer, E J, Haynes, R, Giles, C, Harland, S J, Driver, D, Rustin, G J S, Newlands, E S, Seckl, M J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410221/
https://www.ncbi.nlm.nih.gov/pubmed/15026797
http://dx.doi.org/10.1038/sj.bjc.6601664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410221/
https://www.ncbi.nlm.nih.gov/pubmed/15026797
http://dx.doi.org/10.1038/sj.bjc.6601664

Ejemplares similares